曝光臺(tái) 注意防騙 網(wǎng)曝天貓店富美金盛家居專營(yíng)店坑蒙拐騙欺詐消費(fèi)者

16-APP 3-2 Safety Management Manual (SMM)
2.3 A general intention is that concerns raised by the FDA PROGRAMME should, where possible, be
resolved without identifying the crew concerned. However, there may be occasions when anonymity
is not appropriate, and this document gives protocols to be followed on such occasions in order to
be in accordance with SIN X.
2.4 It is recognized that THE AIRLINE requires an audit trail of actions taken following FDA
PROGRAMME investigations. It is intended that this audit trail will be held within THE AIRLINE in a
manner that satisfies THE AIRLINE’s requirements without being placed on a crew member’s file.
2.5 A further intention is to provide recorded flight data to outside parties (CAA, FAA, universities,
manufacturers, etc.) for research into flight safety. THE PILOTS’ ASSOCIATION will be informed of
each such provision and, if the data are only useful if identified (i.e. can be linked to a specific flight)
then THE AIRLINE will agree with THE PILOTS’ ASSOCIATION to the confidentiality terms under
which the data are provided.
3. CONSTITUTION
The constitution and responsibilities of the Flight Data Recording Group (the “FDA PROGRAMME
Group”) are defined in FCO Y. The Group meets once a month. Membership consists of:
— the Chairman (Flight Manager of the FDA PROGRAMME);
— a representative from each Fleet’s training section;
— a representative from Flight Data Recording (Engineering);
— a representative from Flight Technical Support;
— a Flight Data Analyst from Flight Operations; and
— representatives from THE PILOTS’ ASSOCIATION (currently two short-haul
representatives and one long-haul representative).
The constitution and responsibilities of the Operational Flight Data Recording Working Group are
defined in FCO Y. The Group meets bimonthly. Membership consists of:
— the Chairman (Flight Manager of the FDA PROGRAMME);
— a Flight Data Analyst from Flight Operations;
— Manager Flight Data Recording (Engineering);
— a representative from Flight Technical Support;
— a representative from Safety Services;
— a representative from the CAA Safety Group; and
— a representative from THE PILOTS’ ASSOCIATION.
4. HANDLING
4.1 Scope
This section applies to “events” discovered by the routine running of the FDA PROGRAMME. If a
pilot files an Air Safety Report (ASR) or reports an event to his Manager, then the responsibility for
investigation lies with the Fleet, although the FDA PROGRAMME group may provide assistance. In
this case the pilot is, of course, identified.
Chapter 16. Aircraft Operations
Appendix 3 16-APP 3-3
4.2 The list below gives some of the possible follow-up actions that may be used to investigate a
concern raised by the FDA PROGRAMME. It is not intended to be exhaustive and does not
preclude any other action agreed between THE AIRLINE and THE PILOTS’ ASSOCIATION which is
in accordance with the general intentions above.
Which action is most appropriate in given circumstances will be discussed and agreed between THE
AIRLINE, represented by the Flight Manager of the FDA PROGRAMME and the Fleet FDA
PROGRAMME representative, and THE PILOTS’ ASSOCIATION, represented by the relevant
PILOTS’ ASSOCIATION representative.
A Fleet Manager may request follow-up action. The Fleet Manager will make the request to the Fleet
FDA PROGRAMME representative who will consult with the Flight Manager of the FDA
PROGRAMME and the relevant PILOTS’ ASSOCIATION representative, as above.
4.2.1 THE PILOTS’ ASSOCIATION may be asked to telephone the crew members to debrief an
“event”. The nature of the call can be praise for a well-handled situation, enquiry to elicit
more information about the event and its causes, or a reminder of a relevant Standard
Operating Procedure.
The Fleet Management may ask for specific questions or points to be put to the pilots during
such a call or calls.
In this case, the pilots remain unidentified, and a record of the debriefing will be held in
accordance with Section 5 of this agreement.
4.2.2 THE PILOTS’ ASSOCIATION may be asked to contact a pilot who has a higher than
average FDA PROGRAMME event rate, to advise the pilot and to seek any underlying
reason.
Again, Fleet Management may ask for specific questions or points to be put to the pilots
during such a call or calls.
In this case too, the pilots remain unidentified, and a record of the debriefing will be held in
accordance with Section 5 of this agreement.
4.2.3 The enquiries of 4.2.1 and 4.2.2 above may indicate that “closure” may not be possible
　
中國(guó)航空網(wǎng) www.k6050.com
航空翻譯 www.aviation.cn
本文鏈接地址：Safety Management Manual (SMM) 安全管理手冊(cè)(124)